Awards for Bio-Rad's Protein Expression Products and Genomic Workflow Solutions
News Jan 19, 2015
These annual awards from BioInformatics, a market intelligence provider, recognize the world’s top-performing life science suppliers, as chosen by customers.
BioInformatics announced the winners at a ceremony in Washington, D.C. in November.
“Bio-Rad has long been synonymous with protein analysis,” said Nicole Camara, PhD, senior science advisor at BioInformatics LLC. “But they have been steadily expanding their portfolio of integrated products for genomics researchers, and their more recent focus on Droplet Digital™ PCR (ddPCR™) suggests exciting times ahead for them.”
Bio-Rad’s genomic workflow solutions include PrimePCR™ Assays for real-time PCR and ddPCR, which are expertly designed and experimentally validated for guaranteed performance, and real-rime PCR supermixes that provide robust amplification for even the most challenging templates and target sequences. Bio-Rad also offers real-time PCR detection systems, including CFX Touch Systems that enable researchers to quickly set up runs and monitor amplification traces in real time on an integrated LCD touch screen.
Bio-Rad’s protein expression and analysis solutions include the Bio-Plex® Multiplex System and the V3 Western Workflow™. Bio-Plex immunoassays are built on Luminex xMAP technology and enable the detection and quantification of as many as 500 different protein biomarkers in a single reaction. Bio-Rad’s years of experience with xMAP technology have given the company in-depth knowledge and an understanding of the needs of multiplex users, including their desire for automation and a simplified user experience. The V3 Western Workflow provides researchers with more confidence by creating quality checkpoints — enabled by Bio-Rad’s proprietary stain-free technology — throughout the western workflow. Stain-free technology also underlies stain-free total protein normalization, which has been demonstrated to be more reliable than traditional normalization methods such as using housekeeping proteins.
The Life Science Industry Awards recognize the top life science suppliers in 28 product and service categories. BioInformatics received nominations from more than 5,000 scientific experts in its online community and analyzed the submissions via a quantitative scoring methodology.
“We are honored to be recognized as leaders in both the genomics and protein expression and analysis markets,” said Kate Smith, marketing director of Bio-Rad’s Gene Expression Group. “These Life Science Industry Awards are a reflection of how Bio-Rad strives to develop innovative solutions that provide scientists with the tools to drive their research wherever their imaginations take them.”
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.